Background Medications May Effect On Lupus Clinical Trial Outcomes

Background Medications May Effect on Lupus Clinical Trial Outcomes

Lupus Foundation of America

Increasing Diversity in Lupus Clinical Trials

U.S. Food and Drug Administration

Clinical Trials and New Treatments for Lupus

Lupus Foundation of America

Concordance and discordance in SLE clinical trial outcome measures

Annals of the Rheumatic Diseases

Treating Systemic Lupus Erythematosus: How QSP Can Support Drug Development & Clinical Trial Design

Simulations Plus, Inc.

2017 Lupus PFDD - Current Clinical Thinking on Lupus and Overview of Available Treatments

Lupus Foundation of America

New and Emerging Treatments of Cutaneous Lupus

ClevelandClinicCME

Prof Gordon - Lupus Medication and Pregnancy

Lupus Clinical Trials and Lupus Treatments Video - Brigham and Women's Hospital

Brigham And Women's Hospital

New Systemic Lupus Erythematosus Clinical Trial: DS-7011a for Systemic Lupus Erythematosus

Power Life Sciences

Clinical Trial: Afimetoran for Lupus (NCT04895696)

Power Life Sciences

Lupus Clinical Research Solutions

SLE Nephritis – Biologics Past, Present, and Future

ClevelandClinicCME

The Expert Series S5E7 - Participating in Clinical Trials

Lupus Foundation of America

Lupus drug approved for clinical trials

The CALIBRATE study - A clinical trial for people with lupus nephritis

ImmuneTolerance

New Systemic Lupus Erythematosus Clinical Trial: DS-7011a for Systemic Lupus Erythematosus

Power Life Sciences

Advances in SLE and Vasculitis

ClevelandClinicCME

Diversity and Lupus Clinical Trials: A Conversation with RADM Collins

U.S. Food and Drug Administration

Hot Topics in Lupus: Targeted Biologic Treatment Options